Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Inadequate Response”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04204603
What this trial is testing

A Study Evaluating the Efficacy and Safety of CKD-506 in Adult Subjects With Moderate-to-Severe Rheumatoid Arthritis and Inadequate Response to Methotrexate

Who this might be right for
Rheumatoid Arthritis
Chong Kun Dang Pharmaceutical 122
Not applicableStudy completedNCT00443443
What this trial is testing

The Safety of Rituxan in Patients With Rheumatoid Arthritis After an Inadequate Response to Previous Anti-TNF Therapy (SUNSTONE)

Who this might be right for
Rheumatoid Arthritis
Genentech, Inc. 1,026
Not applicableStudy completedNCT02037737
What this trial is testing

Impact and Use of Abatacept IV for Rheumatoid Arthritis in Real Life Setting

Who this might be right for
Rheumatoid Arthritis
Bristol-Myers Squibb 153
Testing effectiveness (Phase 2)Study completedNCT03813199
What this trial is testing

Study of Two Doses of ABX464 in Participants With Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Abivax S.A. 60
Large-scale testing (Phase 3)Study completedNCT01710358
What this trial is testing

A Study in Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Eli Lilly and Company 1,307
Not applicableEnded earlyNCT00599352
What this trial is testing

Hypovitaminosis D and an Inadequate PTH Response in Chronic Liver Disease Patients

Who this might be right for
Chronic Liver DiseaseHypovitaminosis
Rajib Bhattacharya, MD 14
Large-scale testing (Phase 3)Study completedNCT02079532
What this trial is testing

MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to a Single Anti-TNF Inhibitor

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 302
Testing effectiveness (Phase 2)Study completedNCT03124108
What this trial is testing

Study to Evaluate the Efficacy and Safety of Elafibranor in Patients With Primary Biliary Cholangitis (PBC) and Inadequate Response to Ursodeoxycholic Acid

Who this might be right for
Primary Biliary Cholangitis (PBC)
Genfit 45
Testing effectiveness (Phase 2)Ended earlyNCT05116774
What this trial is testing

BCX9930 for the Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH) in Participants With Inadequate Response to C5 Inhibitor Therapy

Who this might be right for
Paroxysmal Nocturnal Hemoglobinuria (PNH)
BioCryst Pharmaceuticals 12
Large-scale testing (Phase 3)Study completedNCT01106430
What this trial is testing

Comparison of Lisdexamfetamine Dimesylate With Atomoxetine HCl in Attention-Deficit/Hyperactivity Disorder (ADHD) Subjects With an Inadequate Response to Methylphenidate

Who this might be right for
Attention-Deficit/Hyperactivity Disorder
Shire 267
Large-scale testing (Phase 3)Study completedNCT03980483
What this trial is testing

Efficacy and Safety of GSK3196165 Versus Placebo and Tofacitinib in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate

Who this might be right for
Arthritis, Rheumatoid
GlaxoSmithKline 1,537
Testing effectiveness (Phase 2)Study completedNCT00831922
What this trial is testing

Efficacy of Oral AB1010 in Adult Patients With Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
AB Science 43
Testing effectiveness (Phase 2)WithdrawnNCT04965272
What this trial is testing

Assess Adverse Events and Change in Disease Activity With Oral Cariprazine When Added to Antidepressant Therapies (ADTs) Compared to Placebo in Adult Participants With Generalized Anxiety Disorder (GAD) Who Have Had an Inadequate Response to ADTs Alone

Who this might be right for
Generalized Anxiety Disorder
AbbVie
Testing effectiveness (Phase 2)Study completedNCT00902486
What this trial is testing

INCB028050 Compared to Background Therapy in Patients With Active Rheumatoid Arthritis (RA) With Inadequate Response to Disease Modifying Anti-Rheumatic Drugs

Who this might be right for
Rheumatoid Arthritis
Incyte Corporation 127
Large-scale testing (Phase 3)Study completedNCT02305849
What this trial is testing

Evaluate Efficacy and Safety of ASP015K in Patients With Rheumatoid Arthritis (RA) Who Had an Inadequate Response to Methotrexate (MTX) Treatment

Who this might be right for
Rheumatoid Arthritis
Astellas Pharma Inc 519
Large-scale testing (Phase 3)Study completedNCT03308968
What this trial is testing

An Efficacy and Safety Study of Fremanezumab in Adults With Migraine

Who this might be right for
Migraine Prophylaxis
Teva Branded Pharmaceutical Products R&D, Inc. 838
Testing effectiveness (Phase 2)Study completedNCT01960855
What this trial is testing

A Study Investigating the Efficacy and Safety of ABT-494 Given With Methotrexate in Subjects With Rheumatoid Arthritis Who Failed Anti-Tumor Necrosis Factor (TNF) Biologic Therapy

Who this might be right for
Rheumatoid Arthritis
AbbVie 276
Testing effectiveness (Phase 2)Study completedNCT02638948
What this trial is testing

Efficacy and Safety Study of BMS-986142 in Patients With Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Bristol-Myers Squibb 508
Testing effectiveness (Phase 2)WithdrawnNCT01948817
What this trial is testing

Deferasirox BID (Twice a Day) in Transfusion Dependent Thalassemia Patients With Inadequate Response to High Doses

Who this might be right for
Focus on Transfusion Dependent Thalassemia Patients Who Are Inadequate Responders to Deferasirox > 35mg/kgQD
Novartis Pharmaceuticals
Not applicableStudy completedNCT00302913
What this trial is testing

Efficacy of Adjusted Clopidogrel Dose in Patients With Insufficient Platelet Inhibition

Who this might be right for
Coronary Artery DiseaseDrug Resistance
University Heart Center Freiburg - Bad Krozingen 120
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation